Health Condition 1: H184- Corneal degeneration
Conditions
Interventions
None listed
Sponsors
Dr Ankita Omprakash Tripathi
Eligibility
Inclusion criteria
Inclusion criteria: 1. Avrana Shukla with Alpa Vedana and Alpa Strava. 2. Patients willing for Treatment 3. Patient of 20 to 60 yrs. age group 4. Either gender who fulfill the diagnostic criteria. 5. The patients who loss the corneal transparency with diminished of vision and corneal surface is may be regular or irregular but not ulcerated.
Exclusion criteria
Exclusion criteria: Complicated corneal degeneration with large area desquamation Corneal ulcer. Anterior staphyloma, Adherent lucoma , Anterior synechiae and Arcus senilis. Associated with other ocular diseases e.g. Glaucoma 3. Conjunctivitis, Blepharitis, Dacryocystitis, Uveitis etc. other inflammatory diseases. 4. Deep interstitial keratitis, endothelial disease or other corneal ectasia (keratoconus). 5. Valscularized cornea, Keratomalacia, megalocornea,microcornea. 6. Acute systemic or organic disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy of trial drug on Avrana shukla on assessment criteria - Excellent/moderate improvement or ineffective. ShuklaTimepoint: 30 DAYS | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)To evaluate efficacy according to type of corneal haze- a) To assess the efficacy of Triphala-Saindhav ointment in corneal opacity b) To assess the efficacy of Triphala-Saindhav ointment in corneal degeneration c) To assess the efficacy of Triphala-Saindhav ointment in corneal dystrophies d) To assess the efficacy of Triphala-Saindhav ointment in corneal edema.Timepoint: 30 DAYS | — |
Countries
India
Contacts
Public ContactDr NASIR ALI KHAN
Govt, Ayurvedic College and Hospital
Outcome results
None listed